Use of newly approved drugs for patients with early breast cancer (stage I-III) in Germany – data of the prospective, intersectoral research platform OPAL 10. November 2023 Zahn M.-O., Decker T., Thoma M., Nusch A., Müller L., Zaiss M., Beurer B., Buss-Steidle R., Kruggel L., Lennartz C., Jänicke M., Gratzke K., Harbeck N., Wöckel A., Welt A., Thill M., Stickeler E. Download Systemic treatment of cholangiocellular carcinoma in Germany – Results from the prospective national intersectoral cohort study JADE Freiberg-Richter J, Uhlig J, von der Heyde E, Schröder J, Pereira PL, Hofmann WP, et al. Onco Targets Ther. 2023;46 (Suppl.5)(V309):354 Link… Weiterlesen Multiple myeloma: Antiresorptive therapy in patients with osteolytic lesions and impaired renal function – data from the MYRIAM registry von der Heyde, Reiser, M., Nusch, A., Dechow, T., Jacobasch, L., Zingerle, M., Schweizer, C., Medinger, T., Jänicke, M., Potthoff, K., Engelhardt, M., Einsele, H.,… Weiterlesen